Off The $BIS Bus

With the forecast calling for chop, and after four consecutive session of slowing markets, I saw fit to book my biotech short, via BIS, for now.

I still think the ultimate biotech comeuppance is coming—an event so gory it leaves a lasting scar on the psyche of bulls for a generation.  I will revisit this theme at month end and, GOD WILLING, at higher prices.

TBD